Quantcast Potential Pharmaceutical Treatments for Celiac Disease: An Interview with Joseph Murray, MD | NFCA
Skip Navigation Links

Potential Pharmaceutical Treatments for Celiac Disease: An Interview with Joseph Murray, MD

Share |

 
6/10/2013

In advance of the free June webinar, "Celiac Disease: Immunology 101 and the Drug Development Process," the National Foundation for Celiac Awareness (NFCA) asked Joseph Murray, MD, Consultant, Division of Gastroenterology & Hepatology, Professor of Medicine, Mayo Clinic College of Medicine and NFCA Scientific/Medical Advisory Council Member to explain the potential pharmaceutical treatments currently in development for celiac disease.

Download the Q&A with Joseph Murray, MD

Register for "Celiac Disease: Immunlogy 101 and the Drug Development Process," happening on Tuesday, June 11 at 8:30 p.m. EDT/5:30 p.m. PDT here

Note: NFCA maintains the position that views and information presented on articles and websites we link to are those of the authors, and not necessarily those of NFCA.
 

<< Back to Research News


 

 
 
  • Have you or your family members been diagnosed?
    Complete our celiac disease symptoms checklist today to find out if you are at risk of having celiac disease or non-celiac gluten sensitivity ('gluten sensitivity').  We can help improve your quality of life!
  • Stay Informed!
    Join our monthly newsletter to receive news, updates, and tips for healthy gluten-free living and information about celiac disease. Sign-up for the monthly e-mail newsletter